Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 29,112 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke.DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER, BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
Changing stroke rehab and research worldwide now.Time is Brain!trillions and trillions of neuronsthatDIEeach day because there areNOeffective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.
What this blog is for:
My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
Monday, January 8, 2018
Pfizer ends research for new Alzheimer's, Parkinson's drugs
You as a stroke survivor will likely need these. So start saving your pennies to fund your own researchers or create that great stroke association that will simply write RFPs to researchers to solve this and get foundation grants to pay for it. We stroke survivors are completely on our own to fix stroke. Our doctors aren't doing it, our stroke hospitals aren't doing it, our fucking failures of stroke associations certainly aren't doing it. The solutions are out there, we just need researchers to put them into translational interventions. Everyone so far is not a leader, I expect leaders to try for 100% recovery for all.
NEW YORK (Reuters) - Pfizer Inc (PFE.N)
is abandoning research to find new drugs aimed at treating Alzheimer’s
and Parkinson’s disease, the U.S. pharmaceutical company announced on
Saturday.
FILE
PHOTO: The Pfizer logo is seen at their world headquarters in New York
April 28, 2014. REUTERS/Andrew Kelly/File Photo
The
company said it expects to eliminate 300 positions from the
neuroscience discovery and early development programs in Andover and
Cambridge, Massachusetts, and Groton, Connecticut, as it redistributes
the money spent on research, according to the emailed statement.
Pfizer
is not making any changes to research and development funding for
tanezumab, which is marketed as a treatment for joint pain from
osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease
program.
“This was an exercise to re-allocate spend across our
portfolio, to focus on those areas where our pipeline, and our
scientific expertise, is strongest,” the company said.
Pfizer
has invested heavily in research for Parkinson’s and Alzheimer‘s, and
is one of several drugmakers, along with GlaxoSmithKline (GSK.L) and Eli Lilly (LLY.N),
that is part of the Dementia Discovery Fund, a venture capital fund
launched in 2015 by industry and government groups that seeks to develop
treatments for Alzheimer‘s.
However, some of Pfizer’s investments have resulted in disappointment. In 2012, Pfizer and partner Johnson & Johnson (JNJ.N)
called off additional work on the drug bapineuzumab after it failed to
help patients with mild to moderate Alzheimer’s in its second round of
clinical trials.
The company said on Saturday that it will launch a new venture fund to invest in neuroscience research projects.
Pfizer
is expected to make a presentation on Monday at the JP Morgan
healthcare conference in San Francisco, a key annual event for
healthcare investors.
Reporting By Elizabeth Dilts, Editing by Rosalba O'Brien
Pfizer
has invested heavily in research for Parkinson’s and Alzheimer‘s, and
is one of several drugmakers, along with GlaxoSmithKline (GSK.L) and Eli Lilly (LLY.N),
that is part of the Dementia Discovery Fund, a venture capital fund
launched in 2015 by industry and government groups that seeks to develop
treatments for Alzheimer‘s. 
No comments:
Post a Comment